Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Total Current Assets
All assets expected to be converted to cash or used up within one year.
Total Current Assets history
Currency unavailable · from the balance sheet
No Total Current Assets data reported for this period type.
Total Current Assets vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $1.1B USD | +117.9% | +132.0% | 100.0% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $941.49M USD | +165.1% | +100.4% | 76.5% |
| Jun 2026 | $807.15M USD | +34.0% | +33.4% | 91.1% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $514.08M USD | -0.7% | +45.9% | 91.7% |
| Mar 2026 | $316.11M USD | -12.9% | -7.8% | 95.9% | |
| Mar 2026 | $188.76M USD | +894.8% | -43.4% | 99.5% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €133.01M EUR | — | — | 80.3% |
| Mar 2026 | $110.23M USD | +1.3% | -13.2% | 55.5% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +34.0% | +33.4% | 91.4% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.